1. FDA Committee Votes 6-6 on Durect's Non-Opioid Pain Drug — Eli Lilly targets quarterly deals of $1 billion-$5 billion in 2020 — Novo Nordisk's Ozempic wins FDA label boost with CV indication — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

TEI Biosciences

TEI Biosciences


Sort By:
Title ↓
Replies Views
Last Message
  1. Anonymous
    Replies:
    14
    Views:
    3,797
  2. SheDat
    Replies:
    0
    Views:
    4,260
  3. anonymous
    Replies:
    0
    Views:
    2,882
  4. anonymous
    Replies:
    1
    Views:
    2,166
  5. Anonymous
    Replies:
    5
    Views:
    3,680
  6. Anonymous
    Replies:
    53
    Views:
    21,013
  7. Anonymous
    Replies:
    110
    Views:
    36,376
  8. Anonymous
    Replies:
    60
    Views:
    29,178

Thread Display Options

Loading...